DK175572B1 - Anvendelse af phospholipidkapsler til indkapsling af et opoid-analgetika - Google Patents

Anvendelse af phospholipidkapsler til indkapsling af et opoid-analgetika Download PDF

Info

Publication number
DK175572B1
DK175572B1 DK198804081A DK408188A DK175572B1 DK 175572 B1 DK175572 B1 DK 175572B1 DK 198804081 A DK198804081 A DK 198804081A DK 408188 A DK408188 A DK 408188A DK 175572 B1 DK175572 B1 DK 175572B1
Authority
DK
Denmark
Prior art keywords
butorphanol
dose
analgesic
capsules
opoid
Prior art date
Application number
DK198804081A
Other languages
Danish (da)
English (en)
Other versions
DK408188D0 (da
DK408188A (da
Inventor
Leroy Leonard Richer
Original Assignee
Nexstar Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexstar Pharmaceuticals Inc filed Critical Nexstar Pharmaceuticals Inc
Publication of DK408188D0 publication Critical patent/DK408188D0/da
Publication of DK408188A publication Critical patent/DK408188A/da
Application granted granted Critical
Publication of DK175572B1 publication Critical patent/DK175572B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198804081A 1987-07-24 1988-07-21 Anvendelse af phospholipidkapsler til indkapsling af et opoid-analgetika DK175572B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7715587A 1987-07-24 1987-07-24
US7715587 1987-07-24

Publications (3)

Publication Number Publication Date
DK408188D0 DK408188D0 (da) 1988-07-21
DK408188A DK408188A (da) 1989-01-25
DK175572B1 true DK175572B1 (da) 2004-12-13

Family

ID=22136383

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198804081A DK175572B1 (da) 1987-07-24 1988-07-21 Anvendelse af phospholipidkapsler til indkapsling af et opoid-analgetika

Country Status (11)

Country Link
EP (1) EP0300806B1 (ko)
JP (1) JPH01110621A (ko)
KR (1) KR890001518A (ko)
AT (1) ATE110959T1 (ko)
AU (1) AU614527B2 (ko)
CA (1) CA1339076C (ko)
DE (1) DE3851389T2 (ko)
DK (1) DK175572B1 (ko)
ES (1) ES2063758T3 (ko)
IE (1) IE63515B1 (ko)
NO (1) NO883250L (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6785094A (en) * 1993-05-07 1994-12-12 Sequus Pharmaceuticals, Inc. Subcutaneous liposome delivery method
ES2068154B1 (es) * 1993-07-13 1995-11-16 Cantabria Ind Farmaceutica Sa Nuevas formulaciones analgesicas con amplio intervalo de accion.
DE69917000T2 (de) * 1998-02-25 2005-04-21 Abbott Lab Butorphanol enthaltende formulierungen mit verzögerter freisetzung
EP2039360A1 (en) * 2007-09-19 2009-03-25 Euro-Celtique S.A. Non-invasive direct delivery of opioids to the central nervous system
EP2769724A1 (en) * 2013-02-22 2014-08-27 Université d'Aix-Marseille Inhibitors of Na(v) 1.9 channel activity and uses thereof for treating pain
WO2021028916A1 (en) * 2019-08-12 2021-02-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Pharmaceutical compositions comprising a combination of opioid antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0152379A3 (de) * 1984-02-15 1986-10-29 Ciba-Geigy Ag Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
JPH0832623B2 (ja) * 1985-04-10 1996-03-29 ザ リポソ−ム カンパニ−、インコ−ポレ−テッド ステロイドリポソ−ム
FR2592791A1 (fr) * 1986-01-14 1987-07-17 Ire Celltarg Sa Composition pharmaceutique, contenant un anesthesique local et/ou un analgesique central encapsule dans des liposomes
IE63869B1 (en) * 1986-11-06 1995-06-14 Res Dev Foundation Aerosols containing liposomes and method for their preparation

Also Published As

Publication number Publication date
NO883250L (no) 1989-01-25
DK408188D0 (da) 1988-07-21
ATE110959T1 (de) 1994-09-15
JPH01110621A (ja) 1989-04-27
EP0300806B1 (en) 1994-09-07
NO883250D0 (no) 1988-07-21
IE63515B1 (en) 1995-05-03
DK408188A (da) 1989-01-25
AU1926988A (en) 1989-01-27
IE882269L (en) 1989-01-24
DE3851389D1 (de) 1994-10-13
CA1339076C (en) 1997-07-29
ES2063758T3 (es) 1995-01-16
KR890001518A (ko) 1989-03-27
AU614527B2 (en) 1991-09-05
DE3851389T2 (de) 1995-01-19
EP0300806A1 (en) 1989-01-25

Similar Documents

Publication Publication Date Title
ES2303085T3 (es) Composiciones que afectan a la perdida de peso.
SUNG et al. Intravenous verapamil for termination of re-entrant supraventricular tachycardias: intracardiac studies correlated with plasma verapamil concentrations
CN1268338C (zh) 用作止痛剂的6-羟基羟吗啡酮的口服给药
CN103142458B (zh) 无成瘾性镇痛缓释递药系统的组方与制备方法
ES2640572T3 (es) Formulaciones parenterales mejoradas de agentes farmacéuticos lipófilos y procedimientos de preparación y uso de las mismas
Fettiplace et al. Past, present, and future of lipid resuscitation therapy
AU2002316582A1 (en) Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
BRPI0616344A2 (pt) mÉtodo para o tratamento de dependÊncia quÍmica e comportamental
CA2609810A1 (en) Glp-1 analogue formulations
Schwagmeier et al. Pharmacokinetics of intranasal alfentanil
CN107205920A (zh) 可注射丁丙诺啡制剂
DK175572B1 (da) Anvendelse af phospholipidkapsler til indkapsling af et opoid-analgetika
Naidoo THE EFFECTS OF RESERPINE (SERPASIL®) ON THE CHRONIC DISTURBED SCHIZOPHRENIC: A COMPARATIVE STUDY OF RAUWOLFIA ALKALOIDS AND ELECTROCONVULSIVE THERAPY
Mather Opioid pharmacokinetics in relation to their effects
US4576951A (en) Proglumide, pharmaceutical preparations and compositions including it for use in human pain relief
Nieto et al. Comparison of conventional and lipid emulsion formulations of amphotericin B: Pharmacokinetics and toxicokinetics in dogs
Finegan et al. Pharmacokinetics of diltiazem in patients undergoing coronary artery bypass grafting
US20110060037A1 (en) Use of npy y5 receptor antagonists for the prevention of psycho-stimulant and opioid abuse
CN107815438A (zh) 重组细胞、筛选l型钙通道调节剂的方法、试剂在制备药物中的用途和药物组合物
US20220175755A1 (en) Methods of treating tobacco smoking addiction, and treating nicotine and tobacco smoking addiction
JPH11513386A (ja) β−受容体遮断薬とオピオイドとの新規な組合せ物
Movin‐Osswald et al. Influence of the dosing interval on prolactin release after remoxipride.
JP2003514849A (ja) 医薬及び適合性医薬の組み合わせ
McDevitt Position paper: differential features of beta-adrenoreceptor blocking drugs for therapy
US20190015381A1 (en) Cannabinoid Formulation and Products

Legal Events

Date Code Title Description
PUP Patent expired